KRONOS BIO INC's ticker is KRON and the CUSIP is 50107A104. A total of 65 filers reported holding KRONOS BIO INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,886,998 | -24.4% | 1,451,537 | 0.0% | 0.57% | -32.6% |
Q2 2023 | $2,496,644 | +17.8% | 1,451,537 | 0.0% | 0.85% | -4.1% |
Q1 2023 | $2,119,244 | -9.9% | 1,451,537 | 0.0% | 0.88% | -5.3% |
Q4 2022 | $2,351,490 | -51.6% | 1,451,537 | 0.0% | 0.94% | -40.5% |
Q3 2022 | $4,863,000 | -8.0% | 1,451,537 | 0.0% | 1.57% | -11.8% |
Q2 2022 | $5,284,000 | -49.7% | 1,451,537 | 0.0% | 1.78% | -40.5% |
Q1 2022 | $10,495,000 | -46.8% | 1,451,537 | 0.0% | 3.00% | -42.4% |
Q4 2021 | $19,726,000 | – | 1,451,537 | – | 5.20% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vida Ventures Advisors, LLC | 2,765,314 | $19,993,000 | 11.63% |
Omega Fund Management, LLC | 3,818,283 | $27,606,000 | 5.65% |
Nextech Invest Ltd. | 1,451,537 | $10,495,000 | 3.00% |
Wildcat Capital Management, LLC | 1,438,232 | $10,398,000 | 2.66% |
Artal Group S.A. | 1,542,954 | $11,156,000 | 0.47% |
Perceptive Advisors | 2,421,142 | $17,504,000 | 0.35% |
Alphabet Inc. | 1,438,232 | $10,398,000 | 0.34% |
Casdin Capital, LLC | 583,436 | $4,218,000 | 0.19% |
PARTNERS CAPITAL INVESTMENT GROUP, LLP | 527,500 | $3,814,000 | 0.19% |
Samsara BioCapital, LLC | 78,131 | $565,000 | 0.14% |